Synthetic AAV3 Capsid Library Design

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating capsid libraries for AAV vectors suffer from sequence bias and limited diversity, with existing approaches either being limited by sequence bias or producing few functional capsid variants due to random mutations.

Innovation Solution

Development of a non-naturally occurring nucleic acid comprising specific nucleotide sequences encoding AAV Rep and Cap proteins from serotype 3, along with terminal repeats, which are incorporated into vector libraries and AAV virions, allowing for targeted modifications and increased diversity in capsid variants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If random display peptide libraries are used for capsid library generation, then diversity is improved, but sequence bias is introduced due to insertion at one particular capsid location

Engineering Contradiction:
Improvecapsid library diversityVSAvoidsequence bias
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The capsid library generation process is segmented into multiple independent PCR reactions, each targeting specific variable regions (VRs) of the capsid gene. This allows systematic modification of different capsid segments with controlled diversity at each position while maintaining overall capsid structure and function.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different variable regions of the capsid gene are treated with different mutation strategies. Some VRs use random nucleotide incorporation for high diversity, while others use limited amino acid substitutions or recombination. This local customization optimizes diversity where needed while maintaining sequence fidelity in critical regions.

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If error-prone PCR is used to generate capsid variants, then sequence diversity is improved, but the fraction of functional capsid variants is reduced due to excessive random mutations

Engineering Contradiction:
Improvecapsid variant diversityVSAvoidfunctional capsid variant fraction
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The mutation rate and type are precisely controlled by adjusting PCR parameters such as template concentration, primer design, and cycling conditions. This allows generating diversity through point mutations while maintaining a high fraction of functional variants by avoiding excessive or deleterious mutations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Computational analysis is performed before library construction to predict which mutations are likely to maintain capsid function. This preliminary filtering guides the design of primers and PCR conditions to preferentially generate functional variants while still achieving desired diversity.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If DNA shuffling and staggered extension processes are used, then recombination efficiency is improved, but sequence bias occurs because blocks of DNA are recombined rather than single nucleotide positions

Engineering Contradiction:
Improverecombination efficiencyVSAvoidsequence distribution bias
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The capsid gene is divided into multiple overlapping fragments corresponding to different variable regions. These segments are independently amplified and then recombined through controlled PCR, allowing single-nucleotide resolution diversity while maintaining efficient recombination between functional modules.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12188037B2Synthetic combinatorial AAV3 capsid library
Publication Date: 2025.01.07 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US12188037B2 patent drawing
  • US12188037B2 patent drawing
  • US12188037B2 patent drawing

AI summary

Compositions and methods for producing modified AAV Cap genes and combinatorial libraries of chimeric AAV vectors and virions in an AAV serotype 3 background. Selecting for modified AAV3 virions displaying cell- or tissue-specific tropisms differing from WT AAV3. Using the synthetic combinatorial AAV3 capsid libraries for introducing into a selected target host cells one or more nucleic acid molecules useful in diagnostic and/or therapeutic gene-therapy regimens.